D-0385-2025 Class III Terminated
FDA drug recall D-0385-2025 was initiated by OurPharma LLC on Apr 15, 2025 and is designated Class III. Reason for recall: Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification.. The recall status is terminated (terminated Mar 6, 2026). Affected quantity: 1,375 cassettes.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 30, 2025
- Initiation Date
- Apr 15, 2025
- Termination Date
- Mar 6, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,375 cassettes
Product description
HYDROmorphone Hydrochloride 50mg/50mL (1mg/mL), packaged in a 50 mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1040-01.
Reason for recall
Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..
Distribution pattern
Nationwide in the USA
Code information
104024120001, Exp Date 06/01/2025; 104024120002, Exp Date 06/21/2025; 104025010001, Exp Date 07/13/2025; 104025010002, Exp Date 07/28/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0385-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026